Associate Professor, Internal Medicine, Washington University School of Medicine
Oncology
Dr. Amanda Cashen, MD
|
|
Give Review
Amanda Cashen, MD is an expert in the field of Oncology. She attended Washington University School of Medicine in St. Louis. She over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Amanda Cashen is also a published MD. She has 51 publication published. The most recent publication is: Divalproex sodium and other medications for headache following craniotomy for acoustic neuroma. She accepts Medicare.
Publications
- Peri-transplant serum albumin decline predicts subsequent severe Acute graft-versus-host disease following mucotoxic myeloablative conditioning.
- The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
- A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin Lymphoma.
- Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell Lymphoma.
- Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell Lymphoma.
- A cytogenetic model predicts relapse risk and survival in patients with Acute myeloid leukemia undergoing hematopoietic stem cell transplantation in morphologic comple...
- A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma.
- Retrospective comparison of allogeneic vs autologous transplantation for diffuse large B-cell lymphoma with early relapse or primary inDuction failure.
- Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell Lymphoma.
- Prognostic significance of [18F]fluorodeoxyglucose-positron emission tomography in peripheral T-cell Lymphoma treated with stem cell transplantation: a retrospective a...
- A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
- Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias through MLL-AF4.
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.
- Phase I study of oral clofarabine consolidation in adults aged 60 and older with Acute myeloid leukemia.
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Co...
- A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine inDuction in the treatment of AML.
- Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1.
- Decitabine in the treatment of Acute myeloid leukemia in elderly patients.
- Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid Leukemia?
- Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS).
- A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin Lymphoma.
- Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem Cells.
- Impact of mobilization and remobilization strategies on achieving sufficient stem Cell yields for autologous transplantation.
- Salvage regimens for Hodgkin Lymphoma.
- Therapy of relapsed Hodgkin Lymphoma.
- Pharmacokinetics of decitabine administered as a 3-h infusion to patients with Acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
- Mobilizing stem Cells from normal donors: is it possible to improve upon G-CSF?
- AMD3100: CXCR4 antagonist and rapid stem Cell-mobilizing agent.
- Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
- Second complete remission in an elderly patient with Acute myeloid leukemia retreated with decitabine.
- Cytokines and stem Cell mobilization for autologous and allogeneic transplantation.
- 18F-FDG PET/CT for early response assessment in diffuse large B-cell Lymphoma: poor predictive value of international harmonization project interpretation.
- A phase 2 study of high-dose lenalidomide as initial therapy for older patients with Acute myeloid leukemia.
- Multicenter, phase II study of decitabine for the first-line treatment of older patients with Acute myeloid leukemia.
- Plerixafor hydrochloride: a novel agent for the mobilization of peripheral blood stem Cells.
- Salvage therapy for Acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
- A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
- Protein losing enteropathy associated with follicular Lymphoma of the small bowel.
- A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin Lymphoma.
- Extended Retreatment with Brentuximab Vedotin (SGN-35) Maintains Complete Remission in Patient with Recurrent Systemic Anaplastic Large-Cell Lymphoma.
- Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and Acute myeloid leukemia: A phase I study.
- Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study.
- Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin Lymphoma treated with standard salvage chemotherapy and autologous stem cell transplanta...
- High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell Lymphoma that predict response to immuno-chemotherapy.
- Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.
- Divalproex sodium and other medications for headache following craniotomy for acoustic neuroma.
- Allo-SCT conditioning for myelodysplastic syndrome and Acute myeloid leukemia with clofarabine, cytarabine and ATG.
- Leukostasis in adult Acute hyperleukocytic leukemia: a clinician's digest.
Schools
Washington Center School of Medicine
Washington University Barnes Jewish Hospital
Washington University
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University -
Washington University - Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1215953534 | |
| NPPES Provider LastName | CASHEN | |
| NPPES Provider FirstName | AMANDA | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 947.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 56.0 | |
| Percent Opioid Claims | 5.91 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215953534 |
| Last Name Of The Provider | CASHEN |
| First Name Of The Provider | AMANDA |
| View All |
Similar Doctors
|
|
Dr. Peter Westervelt, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Steven M. Pincus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taneemul Haque, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Sorscher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alaa A. Elbendary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lukas D. Wartman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryan A. Faller, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sandeep Sen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna Roshal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Loren S. Michel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria Q. Baggstrom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith E. Stockerl-Goldstein, MD
This Doctor is OpenDoctor Recommended.
|